Dow Down 0.92% Nasdaq Down 0.83%

NovaBay Pharmaceuticals, Inc. (NBY)

-ASE
0.76 Down 0.01(1.50%) 4:00PM EDT
Prev Close:0.77
Open:0.77
Bid:0.70 x 1800
Ask:0.85 x 1000
1y Target Est:1.45
Beta:0.78
Next Earnings Date:N/A
Day's Range:0.75 - 0.77
52wk Range:0.69 - 1.80
Volume:77,907
Avg Vol (3m):310,740
Market Cap:38.39M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBY

Comparison

Symbol% ChgMkt Cap
NBYDown 1.50%38.39M
ABTDown 1.89%62.54B
PFEUp 0.07%179.45B
SNNUp 0.64%14.01B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback